Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia

被引:0
|
作者
Ching-Yen Tsai
Chen-Hsiang Lee
I-Ling Chen
机构
[1] Kaohsiung Chang Gung Memorial Hospital,Department of Internal Medicine, Division of Infectious Diseases
[2] Chang Gung University College of Medicine,Department of Pharmacy
[3] Kaohsiung Chang Gung Memorial Hospital,undefined
[4] School of Pharmacy,undefined
[5] Kaohsiung Medical University,undefined
来源
关键词
β-Lactam; Teicoplanin; Clinical outcome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Miller, William R.
    Seas, Carlos
    Carvajal, Lina P.
    Diaz, Lorena
    Echeverri, Aura M.
    Ferro, Carolina
    Rios, Rafael
    Porras, Paola
    Luna, Carlos
    Gotuzzo, Eduardo
    Munita, Jose M.
    Nannini, Esteban
    Carcamo, Cesar
    Reyes, Jinnethe
    Arias, Cesar A.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (06):
  • [32] Vancomycin-Induced Neutropenia in Status Asthmaticus with Methicillin-Susceptible Staphylococcus Aureus Bacteremia
    Jensen, M.
    Liberg, R.
    Harner, W. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [33] Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?
    Sylvain A. Lother
    Natasha Press
    Current Infectious Disease Reports, 2017, 19
  • [34] Long Term Molecular Epidemiology of Methicillin-Susceptible Staphylococcus aureus Bacteremia Isolates in Sweden
    Rasmussen, Gunloeg
    Monecke, Stefan
    Brus, Ole
    Ehricht, Ralf
    Soederquist, Bo
    PLOS ONE, 2014, 9 (12):
  • [35] Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?
    Lother, Sylvain A.
    Press, Natasha
    CURRENT INFECTIOUS DISEASE REPORTS, 2017, 19 (11)
  • [36] Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy
    G. E. Park
    J.-H. Ko
    S. Y. Cho
    Y. E. Ha
    N. Y. Lee
    C.-I. Kang
    D. R. Chung
    J.-H. Song
    K. R. Peck
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 1091 - 1096
  • [37] Empirical combination of a β-lactam to vancomycin may not improve outcomes of methicillin-susceptible Staphylococcus aureus bacteremia, compared to vancomycin monotherapy
    Park, G. E.
    Ko, J. -H.
    Cho, S. Y.
    Ha, Y. E.
    Lee, N. Y.
    Kang, C. -I.
    Chung, D. R.
    Song, J. -H.
    Peck, K. R.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (07) : 1091 - 1096
  • [38] Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains
    Pujol, M
    Pena, C
    Pallares, R
    Ariza, J
    Ayats, J
    Dominguez, MA
    Gudiol, F
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05): : 509 - 516
  • [39] Comparison of mortality associated with methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia:: An ecological analysis
    Hurley, JC
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) : 866 - 868
  • [40] Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus
    Shurland, Simone
    Zhan, Min
    Bradham, Douglas D.
    Roghmann, Mary-Claire
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (03): : 273 - 279